Afghanistan, Islamic Republic of vs Congo, Democratic Republic of the: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Afghanistan, Islamic Republic of
63.0%
in 2025
Congo, Democratic Republic of the
63.0%
in 2025
Afghanistan, Islamic Republic of rank
140th
Congo, Democratic Republic of the rank
140th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Afghanistan, Islamic Republic of
  • Congo, Democratic Republic of the
020406080200820162025

How they compare

Afghanistan, Islamic Republic of currently reports 63.0% against 63.0% in Congo, Democratic Republic of the, a difference of 0.0%.

The two have swapped places 4 times across 18 shared years of data; in 2008 it was Congo, Democratic Republic of the ahead.

Afghanistan, Islamic Republic of ranks 140th and Congo, Democratic Republic of the ranks 140th of 192 countries.

Congo, Democratic Republic of the has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Afghanistan, Islamic Republic of Congo, Democratic Republic of the Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 36.3% 44.9% 8.6% Congo, Democratic Republic of the
2020s 59.2% 63.5% 4.3% Congo, Democratic Republic of the

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Afghanistan, Islamic Republic of or Congo, Democratic Republic of the?
Afghanistan, Islamic Republic of, at 63.0% against 63.0% in Congo, Democratic Republic of the as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Afghanistan, Islamic Republic of and Congo, Democratic Republic of the?
0.0%, with Afghanistan, Islamic Republic of ahead.
How many years of comparable data are there for Afghanistan, Islamic Republic of and Congo, Democratic Republic of the?
18 years are reported by both, from 2008 to 2025.
How do Afghanistan, Islamic Republic of and Congo, Democratic Republic of the rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Afghanistan, Islamic Republic of ranks 140th and Congo, Democratic Republic of the ranks 140th of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Afghanistan, Islamic Republic of vs Congo, Democratic Republic of the: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 19 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/afghanistan/congo-dem-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/afghanistan/congo-dem-rep/">Afghanistan, Islamic Republic of vs Congo, Democratic Republic of the: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed